Conditions: Inflammation Cataracts
Keywords: Inflammation cataract surgery
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 394
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether IBI-10090 injection is effective in the treatment of inflammation associated with cataract surgery.

Detailed description:
A double blinded randomized trial to assess the efficacy and safety of IBI-10090, in two separate doses as compared to placebo (ATEC carrier only sans dexamethasone)

Arms:
arm 1: IBI-10090 low dose arm 2: IBI-10090 med dose arm 3: Placebo

Interventions: intervention 1: IBI-10090 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: Placebo

Protocol document: